Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 143 blog entries.

End of antiviral medicine prescribing for 2023/24 influenza season

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2023/24 influenza season appeared first on Community Pharmacy England.

By |May 2nd, 2024|Lexpos News|Comments Off on End of antiviral medicine prescribing for 2023/24 influenza season

MHRA Drug Safety Update: April 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment) Montelukast: reminder of the risk of neuropsychiatric reactions Letters [...]

The post MHRA Drug Safety Update: April 2024 appeared first on Community Pharmacy England.

By |April 30th, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: April 2024

10 products added to the Discount Not Deducted (DND) list from May 2024

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 10 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 May 2024. This takes the total [...]

The post 10 products added to the Discount Not Deducted (DND) list from May 2024 appeared first on Community Pharmacy England.

By |April 29th, 2024|Lexpos News|Comments Off on 10 products added to the Discount Not Deducted (DND) list from May 2024

MHRA Class 3 Medicines Recall: Co-Codamol 8/500mg Effervescent tablets (Accord-UK Ltd (Key Pharmaceuticals Livery))

Drug alert number: EL (24)A/12 Date issued: 10 April 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Co-Codamol 8/500mg Effervescent tablets (Accord-UK Ltd (Key Pharmaceuticals Livery)) PL 0142/1258 SNOMED Code: 42596911000001102 Batch No Expiry Date Pack Size First Distributed G2301502 08/2025 8 x 4 tablets 08-Dec-2023 [...]

The post MHRA Class 3 Medicines Recall: Co-Codamol 8/500mg Effervescent tablets (Accord-UK Ltd (Key Pharmaceuticals Livery)) appeared first on Community Pharmacy England.

By |April 10th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Co-Codamol 8/500mg Effervescent tablets (Accord-UK Ltd (Key Pharmaceuticals Livery))

Revised Schedule of Payments expected in April

The look of your monthly Schedule of Payments (and eSchedules) is changing from April 2024. The next payment schedule due to be received on the 23 April (for February 2024 dispensing month) will have several improvements including: Breakdown of Pharmacy First payments, alongside activity data relating to this Total reimbursement and discount deduction split by generics/brands/appliances [...]

The post Revised Schedule of Payments expected in April appeared first on Community Pharmacy England.

By |April 4th, 2024|Lexpos News|Comments Off on Revised Schedule of Payments expected in April